Clinical trial
Randomized Control Trial of Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
NCT01364688 is registered in ClinicalTrials.gov with Ramathibodi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Control Trial of Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
- Lead sponsor
- Ramathibodi Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 31, 2011
- Completion date
- December 31, 2012
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.